Anika Therapeutics, Inc.ANIKNASDAQ
Loading
Year-over-year operating income growth rate
| Period | Value |
|---|---|
| Q4 2025 | 119.98% |
| Q3 2025 | 22.66% |
| Q2 2025 | 2.43% |
| Q1 2025 | -115.40% |
| Q4 2024 | 199.29% |
| Q3 2024 | -1447.90% |
| Q2 2024 | 64.25% |
| Q1 2024 | 92.06% |
| Q4 2023 | -731.13% |
| Q3 2023 | -111.35% |
| Q2 2023 | 71.07% |
| Q1 2023 | -88.29% |
| Q4 2022 | -14.99% |
| Q3 2022 | -71.49% |
| Q2 2022 | 4.87% |
| Q1 2022 | 61.04% |
| Q4 2021 | -801.77% |
| Q3 2021 | -85.84% |
| Q2 2021 | 629.73% |
| Q1 2021 | 107.01% |
| Q4 2020 | -126.48% |
| Q3 2020 | 16.87% |
| Q2 2020 | -234.42% |
| Q1 2020 | 47.73% |
| Q4 2019 | -60.15% |
| Q3 2019 | 1.12% |
| Q2 2019 | 117.35% |
| Q1 2019 | -43.84% |
| Q4 2018 | 13.87% |
| Q3 2018 | -23.77% |
| Q2 2018 | 243.59% |
| Q1 2018 | -180.51% |
| Q4 2017 | -5.27% |
| Q3 2017 | -42.07% |
| Q2 2017 | 121.41% |
| Q1 2017 | -37.16% |
| Q4 2016 | -6.93% |
| Q3 2016 | 1.63% |
| Q2 2016 | 25.77% |
| Q1 2016 | -37.24% |